|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.84 CNY | +3.56% |
|
+3.85% | -36.88% |
| Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
| Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
The company expired its plan on April 3, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.88% | 3.28B | |
| -3.45% | 87.17B | |
| +1.97% | 40.1B | |
| +56.59% | 25.12B | |
| -14.82% | 15.59B | |
| -8.82% | 12B | |
| -16.29% | 11.8B | |
| -41.58% | 11.8B | |
| +6.14% | 8.81B | |
| -10.29% | 8.24B |
WALVAX BIOTECHNOLOGY CO., LTD. 
